ArticleTherapeutic advances in medical oncology2023

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis.

Huijuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.